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Abstract 
Purpose  Dementia is a growing problem worldwide, due to an ageing population. It 
has significant human and economic costs. There is no effective medical treatment.  
Design/methodology Using earlier reviews, we discuss the difference between 
dementia and cognitive ageing and the different types of dementia, in terms of 
manifestation and pathology. We reviewed non-modifiable risk factors for dementia, 
such as age, gender, genetics and education. Education can possibly have lifelong 
protective effects, as it may promote cognitive reserve. This paper focused on 
lifestyle interventions to further increase brain reserve capacity. Findings from earlier 
reviews were summarised to provide guidelines for policymakers and practioners.  
Findings Our reviews suggested that most nutritional approaches may have limited 
effectiveness, and should be implemented in midlife, before dementia symptoms are 
present and probably only in people who are actually nutritionally deficient. We found 
a reasonable positive evidence base of engagement in cognitive and physical 
activities to prevent dementia, which may also help reduce symptoms of dementia.  
Practical and social implications From the studies reviewed, it was suggested that 
keeping physically and mentally active may help in all stages of life to prevent, but 
also reduce dementia symptoms. A focus on nutrition and treating heart disease risk 
factors is possibly limited to midlife, or before dementia symptoms are present. 
Orginality  
We used an evidence based approach to review which lifestyle interventions could 
help prevent dementia or reduce dementia symptoms. The main outcome of this 
paper was that stage of life and ability (dementia present or not) may interact with 
success of the intervention 
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Introduction: What is dementia 
Differences in brain function become larger with age, and not all cognitive functions 
age at the same rate within or between individuals. Cognitive function includes 
learning, memory and other forms of complex information processing, such as 
planning and inhibition, attention, recognition, language and visuospatial functions 
(e.g. used for reading maps). Morbidity (such as heart disease, diabetes mellitus and 
infectious disease) can worsen cognitive function and decline and is more common 
with age. While many of these often chronic diseases share risk factors with 
dementia, dementia is characterised by separate pathology, such as plaques and 
tangles seen in Alzheimer’s disease, the most common type of dementia. So while 
dementia risk increases with age, it is not a normal effect of ageing and it needs to 
be distinguished from other illnesses which can also cause cognitive impairment.  
The question is whether lifestyle changes can reduce dementia risk. We now know 
that what is good for the heart is good for the brain (Kivipelto, 2005; Hogervorst, 
2012). This paper will describe protective lifestyles and dementia risk in more detail, 
but first discusses the most common different types of dementia, their symptoms and 
pathology and then non-modifiable risk factors for dementia.  
Types of dementia 
Dr Alois Alzheimer characterised Alzheimer’s disease pathology in ‘Uber Eine 
Eigenartige Erkrankung der Hirnrinde (on a peculiar disease of the cerebral cortex)’ 
in 1907. He described the tangles and plaques found in the brains of people with this 
form of dementia, which was named after him. Clinically this type of dementia is 
usually characterized by an early loss of memory (problems in memory recall and 
learning of items, names, people and events), resulting in day-to-day forgetfulness, 
which is progressive and shows as a gradual but relentless loss of function. There 
should be other cognitive impairments as the disease progresses, such as visuo-
spatial-; spatial and temporal orientation-; language-; and planning disorders and 
often personality change, which may become apparent early on in the disease in 
some cases. These changes should impact on social and/or occupational function 
and are not caused by other morbidity. For instance, thyroid disease is relatively 
common in older people and can cause memory dysfunction, but it can also usually 
be treated effectively. A clinical depression is seen in 1 in 5 people over 65 years of 
age and is often accompanied by memory problems, but this also responds to 
treatment relatively well. About 70-80% of people treated with antidepressant 
medication or cognitive behavioural therapy show improved mood and memory 
within 3 months. However, some people with AD will have a co-morbid depression 
and depression is thought to be a risk factor for dementia (Barnes & Yaffe, 2011) 
Vascular dementia is the next most common dementia, which progression is often 
more stepwise and which follows after strategic infarcts in the brain and/or extensive 
white matter disease in the brain (Hogervorst, 2003). Vascular dementia usually 
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does not present with severe memory impairments first, as this tends to come later in 
the disease (Hogervorst, 2002b). Vascular dementia shows stepwise focal signs and 
symptoms (e.g. language impairments called aphasia and psychomotor problems 
called apraxia). Another common form of dementia is Lewy Body disease (where we 
find Lewy bodies in neurons which impair their function). It usually is seen with 
Parkinson’s disease symptoms (e.g. the typical mask like face, problems in gait, a 
typical pill rolling tremor of the hands and depression). Lewy Body Disease is further 
characterized by visual hallucinations and confusion, and often language problems 
(word finding) come first, rather than memory impairments. Lastly, frontotemporal 
dementia usually first becomes apparent as personality change and issues with 
planning and inhibition. However, at post-mortem (which is when the diagnoses of 
dementia can only really be confirmed), we often see overlap of the dementia 
pathologies and it is not that common to see only one type of pathology (Hogervorst, 
2003). Because there is no current effective long term treatment for any of these 
dementias, we need to focus on prevention.  
Risk factors we cannot change. 
Age and the female gender are risk factors for Alzheimer’s disease (AD), the most 
common type of dementia. Women were possibly at a higher risk for AD type 
dementia (Launer, 1999), because they tended to reach an older age than men. An 
older age is a risk factor for AD, where at age 65 the risk is still low, this thereafter 
increases with each decade of life. As said, we now know that what is bad for the 
heart is bad for the brain and that includes increased AD risk. It is thought that 
healthy lifestyles traditionally thought to promote heart health (activity, a healthy diet 
with vegetables and fruit, not smoking) may offset some of this risk. However, 
possibly because more women are adapting unhealthy lifestyles (inactivity, smoking, 
alcohol abuse), these gender differences in risk for AD type dementia are now 
reduced in several cohorts (Hogervorst, 2012).  
Another risk factor we cannot change is genetic. Whereas for the relatively rare early 
onset AD (< age 65 years) there may be a stronger genetic link and we can often 
see this occur in first degree relatives, this is less clear for late onset AD. Here a 
genotype called APOE e4 (also associated with risk for heart disease) is thought to 
increase AD risk. When you have one risk allele you double your risk, but if you carry 
both risk alleles (e4/e4, which is rare) your risk for AD might be 8 to 16 times higher. 
On the other hand, about 50% of AD cases do not carry the APOE e4 risk allele and 
about 20% of healthy controls carry one e4 allele but never develop AD (Hogervorst, 
2002). This may be because of brain reserve capacity, which can act as a buffer. 
Several papers (Whalley 2000; Hogervorst, 2013) described the positive relationship 
between childhood IQ and having obtained more education as protective and 
reducing dementia risk by extending the age of onset of dementia. This could reflect 
the effect of a positive childhood (or parental/maternal) experience with safe 
environments (e.g. less neurotoxicity in the environment due to pollution, good 
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nutrition, adequate medical care provided, etc.) and/or access to stimulating 
environments (resulting in having more alternative information and intellectual coping 
when brain function starts to fail). According to the cognitive reserve theory (Esiri 
2012;van Veluw, 2012), the amount of dementia pathology needs to override the 
initial brain reserve. So apart from education, how can we increase this reserve 
capacity? 
Risk factors we can change 
Lifestyle factors may be able to increase brain reserve capacity and reduce dementia 
risk, such as not smoking and no abuse of alcohol; increasing physical activity and 
reducing risk for head injury; and better nutrition (e.g. with sufficient micronutrients, 
such as folate, B12, and anti-oxidants).  
Heart disease risk factors 
Importantly, heart disease risk factors and nutritional deficiencies may be most 
effectively targeted in midlife to reduce later life dementia risk (Hogervorst, 2012). 
The age at onset of dementia is usually over 65 years. Whereas high blood pressure 
as a risk factor for dementia was seen 15 years before onset of the actual disease 
(in midlife), a decrease in blood pressure was shown 1-2 years before the onset of 
dementia (Skoog, 2003). At Oxford University, in the Oxford project To Investigate 
Memory and Ageing we also found that patients with AD often have lower blood 
pressure than age matched controls (Hogervorst, 2002). This suggests that 
hypertension should be treated in midlife, at least two decades before the average 
age at onset of dementia. Similar effects were seen for total cholesterol levels and 
loss of body weight. For instance, in another Scandinavian study, midlife cholesterol 
levels per se were not associated with later life dementia (after 32 years of follow-up), 
but here investigators showed that the drop in cholesterol levels was the best 
predictor of subsequent onset of dementia (Mielke, 2010).   
Dental status 
It may be that blood pressure, cholesterol and weight all drop because the toxic 
plaques and other pathology affect those areas of the brain that are associated with 
metabolism and regulation of blood pressure, such as the autonomic nervous system. 
Another possibility is that these risk factors show a drop because people simply 
forget to eat, which is common in dementia. Because people eat less, they 
subsequently have a lower blood pressure (less weight, less salt intake) and 
cholesterol levels. Lastly, a lowered food intake could be associated with poor dental 
status. In Indonesia we found that elderly who had fewer than 10 teeth had a 
doubled risk for dementia (Hogervorst 2010). This association had also been found 
in the USA and Korea. Having fewer teeth could be the result of forgetting to brush 
your teeth and could result in a lower intake of essential nutrients to reduce dementia 
risk. A combination of factors (forgetfulness, dental status, etc) could of course also 
be possible. 
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Food intake: Vegetables, meat and B vitamins 
Having few teeth can interfere with food intake. This may be particularly true for hard 
to chew meat, whole grains, legumes, green leafy vegetables and nuts, which all 
contain B vitamins. Vitamin B12 has been associated with cognitive function and is 
difficult to obtain for people who do not eat meat or animal protein and only small 
levels are present in whole grains and potatoes. In China we found that both green 
vegetable and meat consumption had an independent positive association with 
memory function and a lower risk for dementia (Xu, 2014). Green vegetables are an 
important source of folate, which is also associated with cognitive function and 
memory. Legumes, such as lentils can also contain high levels of folate.  
In the prospective Kungsholmen and several other studies following people over time, 
low folate or B12 status was associated with a doubled risk for dementia (see Smith, 
2010). This may be because both folate and B12 can reduce levels of homocysteine. 
Homocysteine is a known risk factor for heart disease. In Oxford and other studies 
we found that high homocysteine was associated with markers of dementia in AD, 
such as deep white matter disease (Hogervorst, 2002); medial temporal lobe atrophy 
and cognitive function (Budge et al., 2003), but this was independent of other heart 
disease risk factors. Homocysteine can activate the cell cycle, meaning the neurons 
will try to divide, but end up dying. This could result in a trigger for formation of the 
plaques found in the brain. Homocysteine also sensitises neurons to excitotoxins 
and beta-amyloid toxicity resulting from the plaques.  
Lowering homocysteine levels is possible. A meta-analysis of 12 randomised 
controlled trials found that only 0.5-5mg folic acid reduced homocysteine by 25% and   
0.5 mg B12 further reduced homocysteine levels by 7%. Malouf et al (2003), 
however, showed in a Cochrane meta-analyses of 4 randomized controlled trials that 
there was no evidence for cognitive improvement in people with cognitive impairment 
after folic acid with or without vitamin B12/B6 treatment. In a later update of this 
meta-analyses (2008) with a further 4 studies (8 in total), they reported that there 
was some effect. A later study not included in this meta-analyses also showed a 
small global cognitive effect (vd Zwaluw, 2014) in older people who were folate 
deficient and who had been given folic acid, B12 and vitamin D for 2 years. However, 
these effects were not found on other cognitive domains. In an earlier Dutch study it 
was reported that in people with high homocysteine levels who had been given folic 
acid for 2-3 years, memory and information processing speed was also improved 
(Durga, 2007). A study in Oxford found that B vitamins reduced hippocampal loss by 
30% in those with memory problems, but here these supplements had no effect on 
cognitive outcomes. The hippocampus is implicated in memory and dementia and its 
rate of decline is 10 times faster in people with dementia (Smith, 2010).  
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Our meta-analyses (Lehert, 2015) showed no overall protective effect of B vitamin 
supplementation in treatment trials, but a trend was seen for improved global 
cognitive function and memory. This may be because B vitamin supplements only 
work for people who are folate deficient and/or have high homocysteine levels, but 
do not yet have symptoms of dementia, such as memory impairment. Including 
participants who are folate deficient and those who are not and for whom treatment 
may not be effective could affect analyses. Brain damage in dementia probably 
starts decades before the actually symptoms become apparent and early 
interventions should thus be recommended for those who are folate deficient. In the 
observational Health, Aging & Body Composition we found low homocysteine levels 
after folic acid fortification had been introduced to flour in the USA. We analyses data 
of 3,075 white and African- American elderly aged between 70-79 years, with a 9 
year follow-up to investigate the relationship between health conditions, body 
composition, social and behavioral factors. Of these people, 923 underwent cognitive 
tests and we also measured their bloods for homocysteine, folate, and vitamin B12. 
After fortification with folic acid, we found that nobody in this cohort had a deficiency 
in folate, nobody had homocysteine levels above the risk level (14 umol/L) and there 
was no (longer?) an association between homocysteine or the B vitamins and 
cognitive decline.  
A recent meta-analyses mentioned in the New York Times showed no benefits of 
general vitamin supplements for health and effects of anti-oxidant or other vitamin 
supplements to prevent or treat dementia are much disputed. For instance, our 
meta-analyses showed no overall positive effect of vitamin D supplements on global 
cognition or memory in older people (Lehert, 2015). It is also not clear if there is any 
benefit of vitamin A, C or E. It may be better to eat whole fruits and vegetables, 
whole grains and meats to provide B vitamins and other essential vitamins.  
Food intake: Fats  
Olive oil and the Mediterranean diet 
For instance, it may be the case that other compounds or combinations of foods are 
important in lowering risk for dementia and improving memory and global cognition. 
It was found that a combination of green leafy vegetables and olive oil resulted in an 
increased production of nitro fatty acids, which can lower blood pressure (by blocking 
epoxide hydrolase) (Charles, 2014). These types of salads are common in the 
Mediterranean where heart disease is lower than in the rest of Europe. Olive oil was 
hypothesized to also fight the amyloid plaques in the brains of people with 
Alzheimer’s disease, because it contains a substance called oleocanthal. This 
substance is thought to affect many of the factors implicated in dementia. Infectious 
factors are increasingly thought to play an important role in dementia and olive oil 
was found to improve the immune system. Because olive oil/oleocanthal can also 
improve vascular health, there are thus several reasons why consuming olive oil 
could result in a reduced risk of dementia (Lorida, 2013).  
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However, olive oil is used in the preparation of many Mediterranean dishes, which 
also potentially contain many other health promoting compounds. A review by Lorida 
(2013) showed that 9 of 12 studies (which were mainly observational) suggested that 
eating a Mediterranean diet was associated with better cognitive function, lower 
rates of cognitive decline and a reduced risk of AD. There have been a few treatment 
studies. One study showed that in more than 500 elderly who were at risk for heart 
disease, consuming the Mediterranean diet with added olive oil or nuts over a 6 year 
period (as compared to a low fat diet) gave people less risk of dementia (Martinez-
Lapiscina, 2013). Our meta-analyses showed that adherence to the Mediterranean 
diet with nuts improved general cognition and that this diet with extra olive oil 
improved global cognition and verbal memory in older people. However, effect sizes 
were small (Lehert, 2015). 
Fish Consumption, Nuts and Omega 3 fats 
The Mediterranean diet is varied, but usually also contains fish. The Chicago Health 
and Aging Project showed that cognitive decline was 10% slower among subjects 
who consumed one fish meal per week and 13% slower if they consumed two or 
more fish meals per week (Morris, 2003). Controls in this study consumed more fish 
rich in omega-3 fatty acids (i.e. anchovies, black pomfret) as compared to people 
with Mild Cognitive Impairment (MCI, who are at risk for dementia). Omega 3 fatty 
acids in fish are thought to be neuroprotective, can reduce vascular disease risk and 
non-hemorrhagic stroke risk. Omega 3 has antiarrhythmic, antithrombotic, anti-   
inflammatory and antiatherogenic effects and reduces the synthesis of pro-
inflammatory components, it can also maintain membrane integrity and neuronal 
function. Omega 3 fatty acids play a role in the expression of ß-amyloid, a major 
component of the hallmark plaque pathology in AD. However, treatment studies 
using omega 3 have found contrasting effects and our meta-analyses showed no 
significant overall effect of omega 3 supplements on global cognition or memory 
(Lehert, 2015). Omega-3 is also found in nuts and our meta-analyses found a small 
protective global cognitive effect in people who ate the Mediterranean diet with nuts 
(Lehert, 2015). Again here whole foods rather than supplements may have more 
advantages, as other compounds could interact with one another in providing health 
promoting effects.  
Food intake: isoflavones 
East Asian diets: Fruit and Soy products 
We found in Indonesia that eating fruit reduced risk of dementia and improved 
memory (Hogervorst, 2008). In this cohort, interestingly, we also found that 
consumption of green vegetables and tofu both had negative associations with 
memory and that both increased risk for dementia. For green vegetables this may be 
the case because use of pesticides is high in Indonesia which may have negative 
effects on brain function. For tofu this negative association with it consumption could 
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be related to reports of its preservation in formaldehyde, which is neurotoxic 
(Hogervorst 2008). However, when we sampled tofu in Jakarta we could not find any 
evidence of this, but the practice may have been abolished after it became illegal. 
We also found similar negative associations of tofu and brain function in elderly in 
Hawai’i (Soni et al. 2016) and China (Xu 2014). In contrast, in women of middle-age 
we found that the phytoestrogens present in tofu protected against poor memory 
(Hogervorst 2011). Phytoestrogens, like estrogens, can protect the hippocampus 
against beta amyloid induced damage and have various other protective effects. 
However, (phyto)estrogens could have negative effects on brain function in older 
women (Hogervorst 2014). Treatment studies using soy or phytoestrogen 
supplements have shown variable effects (Soni, 2014) and our meta-analyses 
showed a very small positive effect of soy supplements on memory (Lehert, 2015), 
which was disputable and not clinically very relevant. As suggested, this may be 
related to differences in age of participants tested and the ethnic differences 
between studies (Soni, 2014), but could also be related to other foods in the diet of 
participants. We found associations in people of East Asian origin. In addition, tempe, 
a soy product that is fermented and contains B vitamins, such as folate and vitamin 
B12, was found to improve memory and reduce dementia risk and amyloid markers 
in both humans and animals (Kridawati, 2015, Soni, 2016, Hogervorst, 2010). It may 
be that folate off-sets potential negative effects of high levels of estrogens 
(Hogervorst, 2010) 
 
Activities: physical and cognitive stimulation 
Exercise can lower blood pressure, total cholesterol and improve cardiovascular 
function. It can reduce abdominal fat, which is thought to contain inflammatory 
cytokines (which were in Indonesia and other studies associated with worse 
cognition and dementia risk), it can improve lung and heart function, resulting in 
improved blood flow and better oxygen provision to the brain. It can also directly 
promote outgrowth of nerve cells needed for communication. In Indonesia and the 
UK we found that engaging in physical activity and sports reduced dementia risk and 
improved cognition and also that in those with dementia activity slowed memory 
decline.  While a recent meta-analyses only including larger treatment studies found 
no overall effect of aerobic exercise on cognition, it did report a significant beneficial 
effect of t’ai chi in older people (Lehert, 2015). In contrast to this meta-analyses, our 
earlier reviews and those of others all showed significant beneficial effects of aerobic 
and strength exercise on cognition and physical ability in older without (Clifford, 2010) 
and with dementia (Hogervorst, 2012; McDermott, submitted). The latter review 
reported that three out of seven studies that included walking and four out of five 
studies that included getting up form a chair and walking a set distance (the timed 
get up and go test as an intervention) found beneficial effects on physical ability in 
dementia. One review mentioned optimal benefits of multicomponent exercise for a 
minimum of 12 weeks, 3 times a week for 45-60 minutes.  
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The majority of studies also found positive effects of physical activity on cognitive 
function in people with dementia.  
In the latter review of reviews in humans also beneficial effects of cognitive 
stimulation therapy (but not cognitive training) were reported on brain function in 
people with dementia. Methodological differences between studies were significant 
and made it difficult to compare results and outcomes (Niederstrasser, 2016). A very 
early study in older rats found that an enriched environment increased connections 
between brain cells and it also resulted in more activity in rats (Diamond 1964). A 
large 4-arm 12 weeks treatment trial (Barnes et al., 2013) showed that the more 
older people with cognitive complaints engaged with whatever activity (mental or 
physical or even active control conditions), the better the outcome on cognitive 
function. Similarly, the FINGER study (Ngandu et al., 2015) also showed that 
combining physical and mental activities and reducing heart disease risk factors 
improved cognition and memory in older people at risk for dementia.  
 
Conclusions 
Risk factors for Alzheimer’s disease are the same as those for heart disease, e.g. 
high blood pressure, smoking, high cholesterol, obesity, lack of folate/vit B12 (van 
Osch, 2004; Hogervorst 2002b, Kivipleto, 2005; Barnes & Yaffe, 2011). Each of 
these factors about doubles the risk for dementia, but they act cumulatively (Kivipelto, 
2005), so that if you have midlife high total cholesterol levels, body weight and blood 
pressure your risk for later life dementia could be increased by a factor 6. According 
to Barnes and Yaffe (2011), by preventing diabetes, mid-life hypertension, mid-life 
obesity, smoking, depression, low educational attainment and physical inactivity, 10% 
of AD cases worldwide and 25% in the US could be potentially prevented. Together, 
these risk factors are thought to contribute to up to half of AD cases globally (17.2 
million). Several of these heart disease risk factors (obesity, smoking, high 
cholesterol/blood pressure, nutritional factors etc) probably need to be best treated in 
midlife to reduce the risk of dementia in later life.  
So to reduce heart disease and dementia risk, in midlife at the latest, we need to 
stop smoking (it doubles the risk for dementia), brush our teeth, not eat too many 
sweets and visit the dentist regularly to keep our teeth healthy. This allows us to eat 
the good fats (nuts/fish/olive oil), a little meat, legumes (beans, lentils etc.), plenty of 
vegetables and fruits, and whole grains which is also important to do before 
dementia develops.  
Before and when dementia has developed, conform governmental guidelines and 
reviews, we need to do aerobic exercises (to sweat, increase heart rate and improve 
lung function by walking briskly, or by going cycling or swimming for a total of 150 
min per week) and also engage in muscle strengthening exercises (by using weights 
2-3x/week, for 20-30 min or by heavy gardening (shovelling dirt) or carrying heavy 
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shopping). Improving strength and balance will also reduce the risk for falls, which is 
increased in dementia and which itself increases risk for dementia. During exercise 
and in the heat especially it is very important to keep well hydrated. Adequate 
hydration is important as many older people lose their sense of thirst and often forget 
to drink. Hydration has also been found to improve cognitive function (Masento, 
2014).  
Depression was mentioned as a risk for dementia (Barnes and Yaffe, 2011) and in 
our current projects to treat dementia symptoms, we try to focus on promoting 
mental and physical activities which improve mood, often by including social aspects 
and promoting quality contacts ro reduce loneliness (Steptoe in prep, see also 
http://www.ucl.ac.uk/psychiatry/pride). 
Future studies need to look at long term effects of improving cognitive reserve 
(possibly even through prenatal interventions) and this means that prevention of 
dementia requires a lifelong approach. 
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